Loading…
The results of two-stage revision TKA using Ceftazidime–Vancomycin-impregnated cement articulating spacers in Tsukayama Type II periprosthetic joint infections
Purpose This study examined the success and factors associated with failure, of using cement spacers impregnated with high-dose Ceftazidime and Vancomycin when performing two-stage revision for infected total knee arthroplasty (TKA). Methods A retrospective analysis was performed using a prospective...
Saved in:
Published in: | Knee surgery, sports traumatology, arthroscopy : official journal of the ESSKA sports traumatology, arthroscopy : official journal of the ESSKA, 2016-10, Vol.24 (10), p.3122-3130 |
---|---|
Main Authors: | , , , , , , , , |
Format: | Article |
Language: | English |
Subjects: | |
Citations: | Items that this one cites Items that cite this one |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
cited_by | cdi_FETCH-LOGICAL-c405t-80e2169acae8349515ba8e7e89264b50eb668cc870f71100b7e2e469c1696c1a3 |
---|---|
cites | cdi_FETCH-LOGICAL-c405t-80e2169acae8349515ba8e7e89264b50eb668cc870f71100b7e2e469c1696c1a3 |
container_end_page | 3130 |
container_issue | 10 |
container_start_page | 3122 |
container_title | Knee surgery, sports traumatology, arthroscopy : official journal of the ESSKA |
container_volume | 24 |
creator | Drexler, Michael Dwyer, Tim Kuzyk, Paul R. T. Kosashvilli, Yona Abolghasemian, Mansour Regev, Gilad J. Kadar, Assaf Rutenberg, Tal Frenkel Backstein, David |
description | Purpose
This study examined the success and factors associated with failure, of using cement spacers impregnated with high-dose Ceftazidime and Vancomycin when performing two-stage revision for infected total knee arthroplasty (TKA).
Methods
A retrospective analysis was performed using a prospectively collected database of 82 patients (median age 68 years, range 39–87) with a confirmed deep TKA infection treated with a two-stage revision. All cement spacers were impregnated with high-dose Ceftazidime and Vancomycin. The rate of success was recorded—an association between failure of treatment, and patient factors, previous surgical treatment, and microbial characteristics was sought.
Results
The mean time to infection from index arthroplasty was 45 months (range 3–240). The initial two-stage revision was successful in 70/82 patients (85.4 %), who remained free of infection at average follow-up of 36.2 months (range 24–85). A second two-stage revision for infection was required in 12/82 patients (14.6 %), which was successful in 4/12 (33 %). A third two-stage revision was performed in three patients, all of whom had a polymicrobial infection of which only one patient had successful eradication of infection. Recurrent infection was correlated with irrigation and debridement with implant retention prior to initial two-stage revision (
p
|
doi_str_mv | 10.1007/s00167-015-3753-y |
format | article |
fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_1827934703</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>4203820141</sourcerecordid><originalsourceid>FETCH-LOGICAL-c405t-80e2169acae8349515ba8e7e89264b50eb668cc870f71100b7e2e469c1696c1a3</originalsourceid><addsrcrecordid>eNqNkU2O1DAUhC0EYpqBA7BBltiwMdhOYjvLUYufFiOxadhGbvdLj5vECX7OoMxq7sAJuBonwVEPCCEhsbJlf1XPriLkqeAvBef6FXIulGZcVKzQVcHme2QlyqJguij1fbLidSmZ5JU6I48Qj5znbVk_JGdSSS25EivyfXsFNAJOXUI6tDR9HRgme1gOrz36IdDt-ws6oQ8HuoY22Ru_9z38uP32yQY39LPzgfl-jHAINsGeOughJGpj8m7qbFqEOFoHEanPbjh9trPtLd3OI9DNho4Q_RgHTFeQJfQ4-Cz3oQWX8nh8TB60tkN4creek49vXm_X79jlh7eb9cUlcyWvEjMcpFC1dRZMUdaVqHbWgAZTS1XuKg47pYxzRvNWi5zeToOEUtUui5QTtjgnL06--S1fJsDU9B4ddJ0NMEzYCCN1nXPlxf-gSonaCJ3R53-hx2GKIX9koSojpKnKTIkT5XIOGKFtxuh7G-dG8GapujlV3eSqm6XqZs6aZ3fO066H_W_Fr24zIE8A5qtwgPjH6H-6_gTzgLfF</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1825812854</pqid></control><display><type>article</type><title>The results of two-stage revision TKA using Ceftazidime–Vancomycin-impregnated cement articulating spacers in Tsukayama Type II periprosthetic joint infections</title><source>EBSCOhost SPORTDiscus with Full Text</source><source>Wiley-Blackwell Read & Publish Collection</source><source>Springer Link</source><creator>Drexler, Michael ; Dwyer, Tim ; Kuzyk, Paul R. T. ; Kosashvilli, Yona ; Abolghasemian, Mansour ; Regev, Gilad J. ; Kadar, Assaf ; Rutenberg, Tal Frenkel ; Backstein, David</creator><creatorcontrib>Drexler, Michael ; Dwyer, Tim ; Kuzyk, Paul R. T. ; Kosashvilli, Yona ; Abolghasemian, Mansour ; Regev, Gilad J. ; Kadar, Assaf ; Rutenberg, Tal Frenkel ; Backstein, David</creatorcontrib><description>Purpose
This study examined the success and factors associated with failure, of using cement spacers impregnated with high-dose Ceftazidime and Vancomycin when performing two-stage revision for infected total knee arthroplasty (TKA).
Methods
A retrospective analysis was performed using a prospectively collected database of 82 patients (median age 68 years, range 39–87) with a confirmed deep TKA infection treated with a two-stage revision. All cement spacers were impregnated with high-dose Ceftazidime and Vancomycin. The rate of success was recorded—an association between failure of treatment, and patient factors, previous surgical treatment, and microbial characteristics was sought.
Results
The mean time to infection from index arthroplasty was 45 months (range 3–240). The initial two-stage revision was successful in 70/82 patients (85.4 %), who remained free of infection at average follow-up of 36.2 months (range 24–85). A second two-stage revision for infection was required in 12/82 patients (14.6 %), which was successful in 4/12 (33 %). A third two-stage revision was performed in three patients, all of whom had a polymicrobial infection of which only one patient had successful eradication of infection. Recurrent infection was correlated with irrigation and debridement with implant retention prior to initial two-stage revision (
p
< 0.01), polymicrobial infections (
p
= 0.035), and infections presenting <6 months after index surgery (
p
= 0.031). No correlation was seen with age, BMI, type of organism, diabetes mellitus, or Charlson Comorbidity Index.
Conclusion
The findings of this study suggest that the combination of Ceftazidime and Vancomycin in cement spacers is as efficacious as other published single or combined antibiotic mixtures, which is clinically relevant to clinicians treating this difficult problem in the setting of patients with compromised renal function.</description><identifier>ISSN: 0942-2056</identifier><identifier>EISSN: 1433-7347</identifier><identifier>DOI: 10.1007/s00167-015-3753-y</identifier><identifier>PMID: 26272061</identifier><language>eng</language><publisher>Berlin/Heidelberg: Springer Berlin Heidelberg</publisher><subject>Adult ; Aged ; Aged, 80 and over ; Anti-Bacterial Agents - administration & dosage ; Antibiotics ; Arthroplasty, Replacement, Knee - adverse effects ; Bacteria ; Bone Cements ; Ceftazidime - administration & dosage ; Female ; Gram-negative bacteria ; Humans ; Infections ; Joint replacement surgery ; Knee ; Knee Prosthesis - adverse effects ; Male ; Medicine ; Medicine & Public Health ; Middle Aged ; Orthopedics ; Patients ; Polymethyl methacrylate ; Prosthesis-Related Infections - classification ; Prosthesis-Related Infections - microbiology ; Prosthesis-Related Infections - therapy ; Reoperation - methods ; Retrospective Studies ; Success ; Transplants & implants ; Vancomycin - administration & dosage</subject><ispartof>Knee surgery, sports traumatology, arthroscopy : official journal of the ESSKA, 2016-10, Vol.24 (10), p.3122-3130</ispartof><rights>European Society of Sports Traumatology, Knee Surgery, Arthroscopy (ESSKA) 2015</rights><rights>European Society of Sports Traumatology, Knee Surgery, Arthroscopy (ESSKA) 2016</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c405t-80e2169acae8349515ba8e7e89264b50eb668cc870f71100b7e2e469c1696c1a3</citedby><cites>FETCH-LOGICAL-c405t-80e2169acae8349515ba8e7e89264b50eb668cc870f71100b7e2e469c1696c1a3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27924,27925</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/26272061$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Drexler, Michael</creatorcontrib><creatorcontrib>Dwyer, Tim</creatorcontrib><creatorcontrib>Kuzyk, Paul R. T.</creatorcontrib><creatorcontrib>Kosashvilli, Yona</creatorcontrib><creatorcontrib>Abolghasemian, Mansour</creatorcontrib><creatorcontrib>Regev, Gilad J.</creatorcontrib><creatorcontrib>Kadar, Assaf</creatorcontrib><creatorcontrib>Rutenberg, Tal Frenkel</creatorcontrib><creatorcontrib>Backstein, David</creatorcontrib><title>The results of two-stage revision TKA using Ceftazidime–Vancomycin-impregnated cement articulating spacers in Tsukayama Type II periprosthetic joint infections</title><title>Knee surgery, sports traumatology, arthroscopy : official journal of the ESSKA</title><addtitle>Knee Surg Sports Traumatol Arthrosc</addtitle><addtitle>Knee Surg Sports Traumatol Arthrosc</addtitle><description>Purpose
This study examined the success and factors associated with failure, of using cement spacers impregnated with high-dose Ceftazidime and Vancomycin when performing two-stage revision for infected total knee arthroplasty (TKA).
Methods
A retrospective analysis was performed using a prospectively collected database of 82 patients (median age 68 years, range 39–87) with a confirmed deep TKA infection treated with a two-stage revision. All cement spacers were impregnated with high-dose Ceftazidime and Vancomycin. The rate of success was recorded—an association between failure of treatment, and patient factors, previous surgical treatment, and microbial characteristics was sought.
Results
The mean time to infection from index arthroplasty was 45 months (range 3–240). The initial two-stage revision was successful in 70/82 patients (85.4 %), who remained free of infection at average follow-up of 36.2 months (range 24–85). A second two-stage revision for infection was required in 12/82 patients (14.6 %), which was successful in 4/12 (33 %). A third two-stage revision was performed in three patients, all of whom had a polymicrobial infection of which only one patient had successful eradication of infection. Recurrent infection was correlated with irrigation and debridement with implant retention prior to initial two-stage revision (
p
< 0.01), polymicrobial infections (
p
= 0.035), and infections presenting <6 months after index surgery (
p
= 0.031). No correlation was seen with age, BMI, type of organism, diabetes mellitus, or Charlson Comorbidity Index.
Conclusion
The findings of this study suggest that the combination of Ceftazidime and Vancomycin in cement spacers is as efficacious as other published single or combined antibiotic mixtures, which is clinically relevant to clinicians treating this difficult problem in the setting of patients with compromised renal function.</description><subject>Adult</subject><subject>Aged</subject><subject>Aged, 80 and over</subject><subject>Anti-Bacterial Agents - administration & dosage</subject><subject>Antibiotics</subject><subject>Arthroplasty, Replacement, Knee - adverse effects</subject><subject>Bacteria</subject><subject>Bone Cements</subject><subject>Ceftazidime - administration & dosage</subject><subject>Female</subject><subject>Gram-negative bacteria</subject><subject>Humans</subject><subject>Infections</subject><subject>Joint replacement surgery</subject><subject>Knee</subject><subject>Knee Prosthesis - adverse effects</subject><subject>Male</subject><subject>Medicine</subject><subject>Medicine & Public Health</subject><subject>Middle Aged</subject><subject>Orthopedics</subject><subject>Patients</subject><subject>Polymethyl methacrylate</subject><subject>Prosthesis-Related Infections - classification</subject><subject>Prosthesis-Related Infections - microbiology</subject><subject>Prosthesis-Related Infections - therapy</subject><subject>Reoperation - methods</subject><subject>Retrospective Studies</subject><subject>Success</subject><subject>Transplants & implants</subject><subject>Vancomycin - administration & dosage</subject><issn>0942-2056</issn><issn>1433-7347</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2016</creationdate><recordtype>article</recordtype><recordid>eNqNkU2O1DAUhC0EYpqBA7BBltiwMdhOYjvLUYufFiOxadhGbvdLj5vECX7OoMxq7sAJuBonwVEPCCEhsbJlf1XPriLkqeAvBef6FXIulGZcVKzQVcHme2QlyqJguij1fbLidSmZ5JU6I48Qj5znbVk_JGdSSS25EivyfXsFNAJOXUI6tDR9HRgme1gOrz36IdDt-ws6oQ8HuoY22Ru_9z38uP32yQY39LPzgfl-jHAINsGeOughJGpj8m7qbFqEOFoHEanPbjh9trPtLd3OI9DNho4Q_RgHTFeQJfQ4-Cz3oQWX8nh8TB60tkN4creek49vXm_X79jlh7eb9cUlcyWvEjMcpFC1dRZMUdaVqHbWgAZTS1XuKg47pYxzRvNWi5zeToOEUtUui5QTtjgnL06--S1fJsDU9B4ddJ0NMEzYCCN1nXPlxf-gSonaCJ3R53-hx2GKIX9koSojpKnKTIkT5XIOGKFtxuh7G-dG8GapujlV3eSqm6XqZs6aZ3fO066H_W_Fr24zIE8A5qtwgPjH6H-6_gTzgLfF</recordid><startdate>20161001</startdate><enddate>20161001</enddate><creator>Drexler, Michael</creator><creator>Dwyer, Tim</creator><creator>Kuzyk, Paul R. T.</creator><creator>Kosashvilli, Yona</creator><creator>Abolghasemian, Mansour</creator><creator>Regev, Gilad J.</creator><creator>Kadar, Assaf</creator><creator>Rutenberg, Tal Frenkel</creator><creator>Backstein, David</creator><general>Springer Berlin Heidelberg</general><general>Springer Nature B.V</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7QO</scope><scope>7RV</scope><scope>7TS</scope><scope>7X7</scope><scope>7XB</scope><scope>88E</scope><scope>8AO</scope><scope>8FD</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>BENPR</scope><scope>CCPQU</scope><scope>FR3</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>K9.</scope><scope>KB0</scope><scope>M0S</scope><scope>M1P</scope><scope>NAPCQ</scope><scope>P64</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>7X8</scope></search><sort><creationdate>20161001</creationdate><title>The results of two-stage revision TKA using Ceftazidime–Vancomycin-impregnated cement articulating spacers in Tsukayama Type II periprosthetic joint infections</title><author>Drexler, Michael ; Dwyer, Tim ; Kuzyk, Paul R. T. ; Kosashvilli, Yona ; Abolghasemian, Mansour ; Regev, Gilad J. ; Kadar, Assaf ; Rutenberg, Tal Frenkel ; Backstein, David</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c405t-80e2169acae8349515ba8e7e89264b50eb668cc870f71100b7e2e469c1696c1a3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2016</creationdate><topic>Adult</topic><topic>Aged</topic><topic>Aged, 80 and over</topic><topic>Anti-Bacterial Agents - administration & dosage</topic><topic>Antibiotics</topic><topic>Arthroplasty, Replacement, Knee - adverse effects</topic><topic>Bacteria</topic><topic>Bone Cements</topic><topic>Ceftazidime - administration & dosage</topic><topic>Female</topic><topic>Gram-negative bacteria</topic><topic>Humans</topic><topic>Infections</topic><topic>Joint replacement surgery</topic><topic>Knee</topic><topic>Knee Prosthesis - adverse effects</topic><topic>Male</topic><topic>Medicine</topic><topic>Medicine & Public Health</topic><topic>Middle Aged</topic><topic>Orthopedics</topic><topic>Patients</topic><topic>Polymethyl methacrylate</topic><topic>Prosthesis-Related Infections - classification</topic><topic>Prosthesis-Related Infections - microbiology</topic><topic>Prosthesis-Related Infections - therapy</topic><topic>Reoperation - methods</topic><topic>Retrospective Studies</topic><topic>Success</topic><topic>Transplants & implants</topic><topic>Vancomycin - administration & dosage</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Drexler, Michael</creatorcontrib><creatorcontrib>Dwyer, Tim</creatorcontrib><creatorcontrib>Kuzyk, Paul R. T.</creatorcontrib><creatorcontrib>Kosashvilli, Yona</creatorcontrib><creatorcontrib>Abolghasemian, Mansour</creatorcontrib><creatorcontrib>Regev, Gilad J.</creatorcontrib><creatorcontrib>Kadar, Assaf</creatorcontrib><creatorcontrib>Rutenberg, Tal Frenkel</creatorcontrib><creatorcontrib>Backstein, David</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Biotechnology Research Abstracts</collection><collection>Nursing & Allied Health Database</collection><collection>Physical Education Index</collection><collection>Health & Medical Collection (Proquest)</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Medical Database (Alumni Edition)</collection><collection>ProQuest Pharma Collection</collection><collection>Technology Research Database</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni)</collection><collection>ProQuest Central</collection><collection>AUTh Library subscriptions: ProQuest Central</collection><collection>ProQuest One Community College</collection><collection>Engineering Research Database</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>Nursing & Allied Health Database (Alumni Edition)</collection><collection>Health & Medical Collection (Alumni Edition)</collection><collection>Medical Database</collection><collection>Nursing & Allied Health Premium</collection><collection>Biotechnology and BioEngineering Abstracts</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>MEDLINE - Academic</collection><jtitle>Knee surgery, sports traumatology, arthroscopy : official journal of the ESSKA</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Drexler, Michael</au><au>Dwyer, Tim</au><au>Kuzyk, Paul R. T.</au><au>Kosashvilli, Yona</au><au>Abolghasemian, Mansour</au><au>Regev, Gilad J.</au><au>Kadar, Assaf</au><au>Rutenberg, Tal Frenkel</au><au>Backstein, David</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>The results of two-stage revision TKA using Ceftazidime–Vancomycin-impregnated cement articulating spacers in Tsukayama Type II periprosthetic joint infections</atitle><jtitle>Knee surgery, sports traumatology, arthroscopy : official journal of the ESSKA</jtitle><stitle>Knee Surg Sports Traumatol Arthrosc</stitle><addtitle>Knee Surg Sports Traumatol Arthrosc</addtitle><date>2016-10-01</date><risdate>2016</risdate><volume>24</volume><issue>10</issue><spage>3122</spage><epage>3130</epage><pages>3122-3130</pages><issn>0942-2056</issn><eissn>1433-7347</eissn><abstract>Purpose
This study examined the success and factors associated with failure, of using cement spacers impregnated with high-dose Ceftazidime and Vancomycin when performing two-stage revision for infected total knee arthroplasty (TKA).
Methods
A retrospective analysis was performed using a prospectively collected database of 82 patients (median age 68 years, range 39–87) with a confirmed deep TKA infection treated with a two-stage revision. All cement spacers were impregnated with high-dose Ceftazidime and Vancomycin. The rate of success was recorded—an association between failure of treatment, and patient factors, previous surgical treatment, and microbial characteristics was sought.
Results
The mean time to infection from index arthroplasty was 45 months (range 3–240). The initial two-stage revision was successful in 70/82 patients (85.4 %), who remained free of infection at average follow-up of 36.2 months (range 24–85). A second two-stage revision for infection was required in 12/82 patients (14.6 %), which was successful in 4/12 (33 %). A third two-stage revision was performed in three patients, all of whom had a polymicrobial infection of which only one patient had successful eradication of infection. Recurrent infection was correlated with irrigation and debridement with implant retention prior to initial two-stage revision (
p
< 0.01), polymicrobial infections (
p
= 0.035), and infections presenting <6 months after index surgery (
p
= 0.031). No correlation was seen with age, BMI, type of organism, diabetes mellitus, or Charlson Comorbidity Index.
Conclusion
The findings of this study suggest that the combination of Ceftazidime and Vancomycin in cement spacers is as efficacious as other published single or combined antibiotic mixtures, which is clinically relevant to clinicians treating this difficult problem in the setting of patients with compromised renal function.</abstract><cop>Berlin/Heidelberg</cop><pub>Springer Berlin Heidelberg</pub><pmid>26272061</pmid><doi>10.1007/s00167-015-3753-y</doi><tpages>9</tpages></addata></record> |
fulltext | fulltext |
identifier | ISSN: 0942-2056 |
ispartof | Knee surgery, sports traumatology, arthroscopy : official journal of the ESSKA, 2016-10, Vol.24 (10), p.3122-3130 |
issn | 0942-2056 1433-7347 |
language | eng |
recordid | cdi_proquest_miscellaneous_1827934703 |
source | EBSCOhost SPORTDiscus with Full Text; Wiley-Blackwell Read & Publish Collection; Springer Link |
subjects | Adult Aged Aged, 80 and over Anti-Bacterial Agents - administration & dosage Antibiotics Arthroplasty, Replacement, Knee - adverse effects Bacteria Bone Cements Ceftazidime - administration & dosage Female Gram-negative bacteria Humans Infections Joint replacement surgery Knee Knee Prosthesis - adverse effects Male Medicine Medicine & Public Health Middle Aged Orthopedics Patients Polymethyl methacrylate Prosthesis-Related Infections - classification Prosthesis-Related Infections - microbiology Prosthesis-Related Infections - therapy Reoperation - methods Retrospective Studies Success Transplants & implants Vancomycin - administration & dosage |
title | The results of two-stage revision TKA using Ceftazidime–Vancomycin-impregnated cement articulating spacers in Tsukayama Type II periprosthetic joint infections |
url | http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-25T15%3A23%3A49IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=The%20results%20of%20two-stage%20revision%20TKA%20using%20Ceftazidime%E2%80%93Vancomycin-impregnated%20cement%20articulating%20spacers%20in%20Tsukayama%20Type%20II%20periprosthetic%20joint%20infections&rft.jtitle=Knee%20surgery,%20sports%20traumatology,%20arthroscopy%20:%20official%20journal%20of%20the%20ESSKA&rft.au=Drexler,%20Michael&rft.date=2016-10-01&rft.volume=24&rft.issue=10&rft.spage=3122&rft.epage=3130&rft.pages=3122-3130&rft.issn=0942-2056&rft.eissn=1433-7347&rft_id=info:doi/10.1007/s00167-015-3753-y&rft_dat=%3Cproquest_cross%3E4203820141%3C/proquest_cross%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c405t-80e2169acae8349515ba8e7e89264b50eb668cc870f71100b7e2e469c1696c1a3%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=1825812854&rft_id=info:pmid/26272061&rfr_iscdi=true |